Menopause Treatment London


menopause treatment LondonMenopause Treatment London: A Natural Alternative to HRT

Menopause Treatment London: We provide a safe, natural alternative to HRT. Natural treatment to support a woman through the menopause. Each prescription is formulated to meet each patient’s unique needs. Natural Medicine has become a popular, safe and effective alternative for women with debilitating menopausal symptoms, particularly in the light of the Women’s Health Initiative (WHI) study of 2002, which suggested that health risks may exceed benefits during prolonged hormone replacement therapy (HRT).

The effect of the initial publications of the WHI resulted in a decline in HRT use of around 50% in the UK. Recent research funded by the National Institutes of Health (NIH) in the USA, one of the world’s foremost medical research centres, states that “the study of alternative therapies for menopause symptoms is a rewarding and important area deserving of further inquiry”. The NHS is also listing several herbs in their leaflet on alternative therapies for the treatment of menopausal symptoms.

We have successfully treated many women, who come to our clinic for help in alleviating uncomfortable and debilitating menopausal symptoms. In most cases it is easy to get significant results in a relatively short period of time. Most patients are feeling considerably better by the time of their first follow-up consultation, which is usually four weeks after the initial consultation.

Our natural menopause treatment London clinic can alleviate hot flushes and night sweats. We also address, where necessary, any anxiety, stress or depression that may be present. Patients feel the benefit of this, reporting that they feel more like their old self. The natural treatment supports the body, while the transition (menopause) takes place. Patients are gradually taken off the natural medication, once the body has settled into menopause and there are no longer any unpleasant symptoms. The time factor is different for each woman as we are all unique.

References:

Postmenopausal health interventions: Time to move on from the Women’s Health Initiative?
Thaung Zaw JJ, Howe PRC, Wong RHX.
Ageing Res Rev. 2018 Dec;48:79-86. doi: 10.1016/j.arr.2018.10.005. Epub 2018 Oct 21.
PMID: 30355506 Review.
Hormone therapy (HT) used to be the standard of care for managing vasomotor symptoms and prevention of chronic diseases until publication of the Women’s Health Initiative (WHI) in 2002. …Alternative therapies such as phytoestrogens and non-hor …

An Update on Menopause Management.
Ward K, Deneris A.
J Midwifery Womens Health. 2018 Mar;63(2):168-177. doi: 10.1111/jmwh.12737. Epub 2018 Mar 9.
PMID: 29522279 Review.
Menopause-related symptoms frequently lead women to seek health care. Recommendations for prescribing hormone therapy have changed significantly since the publication of initial results from the Women’s Health Initiative (WHI) study in …

The Controversial History of Hormone Replacement Therapy.
Cagnacci A, Venier M.
Medicina (Kaunas). 2019 Sep 18;55(9):602. doi: 10.3390/medicina55090602.
PMID: 31540401 Free PMC article. Review.
After the announcement of the first results of the Women’s Health Initiative (WHI) in 2002, which showed that HRT had more detrimental than beneficial effects, HRT use dropped. …Notwithstanding this, the public opinion on HRT has not changed y …

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women’s Health Initiative Investigators.
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
PMID: 12117397 Free article. Clinical Trial.
DESIGN: Estrogen plus progestin component of the Women’s Health Initiative, a randomized controlled primary prevention trial (planned duration, 8.5 years) in which 16608 postmenopausal women aged 50-79 years with an intact uterus at baseline wer …

Menopausal hormone therapy trends before versus after 2002: impact of the Women’s Health Initiative Study Results.
Crawford SL, Crandall CJ, Derby CA, El Khoudary SR, Waetjen LE, Fischer M, Joffe H.
Menopause. 2018 Dec 21;26(6):588-597. doi: 10.1097/GME.0000000000001282.
PMID: 30586004 Free PMC article. Clinical Trial.
OBJECTIVE: To better understand how to educate patients and providers about study findings relevant to treatment guidelines, we assessed pre- versus post-Women’s Health Initiative (WHI) differences in menopausal hormone therapy (MHT) initiation and con …

Current Evidence of the Oncological Benefit-Risk Profile of Hormone Replacement Therapy.
D’Alonzo M, Bounous VE, Villa M, Biglia N.
Medicina (Kaunas). 2019 Sep 7;55(9):573. doi: 10.3390/medicina55090573.
PMID: 31500261 Free PMC article. Review.
The progestogen is added to provide endometrial protection in women with an intact uterus. After the publication of the initial WHI (Women’s Health Initiative) results in 2002 reporting an overall increased risk of breast cancer, many …

Where are we 10 years after the Women’s Health Initiative?
Lobo RA.
J Clin Endocrinol Metab. 2013 May;98(5):1771-80. doi: 10.1210/jc.2012-4070. Epub 2013 Mar 14.
PMID: 23493433 Review.
Although in 2002 it was stated that the results pertained to all women receiving HT, subsequent studies from the Women’s Health Initiative (WHI) and others clearly showed that younger women and those close to menopause had a very b …

The evidence base for HRT: what can we believe?
Langer RD.
Climacteric. 2017 Apr;20(2):91-96. doi: 10.1080/13697137.2017.1280251. Epub 2017 Mar 10.
PMID: 28281363 Review.
Prior to the unexpected early termination of the Women’s Health Initiative (WHI) trial of continuous conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA), the prevailing view was that hormone replacement therapy (HRT) was a low-risk …

Increased Incidence of Endometrial Cancer Following the Women’s Health Initiative: An Assessment of Risk Factors.
Constantine GD, Kessler G, Graham S, Goldstein SR.
J Womens Health (Larchmt). 2019 Feb;28(2):237-243. doi: 10.1089/jwh.2018.6956. Epub 2018 Nov 28.
PMID: 30484734 Free PMC article.
RESULTS: Although endometrial cancer rates were constant from 1992 to 2002 (women 50-74 years of age), they increased 2.5% annually with a 10% increase from 2006 to 2012 (trend test 0.82). Use of approved prescription estrogen-progestogen combination products decrea …


If you would like a natural approach to menopausal symptoms

Contact Deborah’s Medical Secretary for an appointment